Evidence map›Paper›PMID 37440483›Full record

ArticlePloS one2023

Klebsiella pneumoniae carbapenamases in Escherichia coli isolated from humans and livestock in rural south-western Uganda.

Barbra Tuhamize, Benon B Asiimwe, Kennedy Kasaza, Wilber Sabiiti, Mathew Holden, Joel Bazira

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Antibiotic resistance ofJournal of water and health · 2024
    Article
  10. Review
  11. Monitoring Multi-Drug ResistantInfection and drug resistance · 2024
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Barbra TuhamizeDepartment of Microbiology, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0002-1243-4901
Benon B AsiimweDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Kennedy KasazaDepartment of Microbiology, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0003-2097-4622
Wilber SabiitiDivision of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, United Kingdom.
Mathew HoldenDivision of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, United Kingdom.
Joel BaziraDepartment of Microbiology, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.ORCID 0000-0001-7600-7514
Mbarara University of Science and Technology · UGUniversity of St Andrews · GBMakerere University · UG

Funding

Medical Research Council MR/S004785/1
6 · The paper itself

Abstract

backgroundThe accumulation of resistance genes in Escherichia coli (E. coli) strains imposes limitations in the therapeutic options available for the treatment of infections caused by E.coli. Production of Klebsiella pneumoniae carbapenemase (KPC) by E. coli renders it resistant to broad-spectrum β-lactam antibiotics. Globally there is existing evidence of spread of carbapenem-resistant E. coli in both humans and livestock driven by acquisition of the several other carbapenemase genes. Overall, there is little information regarding the extent of KPC gene distribution in E. coli. We set out to determine the prevalence, and evaluate the phenotypic and genotypic patterns of KPC in E. coli isolated from humans and their livestock in rural south western Uganda.

methodsA laboratory-based, descriptive cross-sectional study was conducted involving 96 human and 96 livestock isolates collected from agro-pastoralist communities in Mbarara district in south western Uganda. Phenotypic and molecular methods (PCR) were used for presence and identification of KPC genes in the E. coli isolates. A chi-square test of independence was used to evaluate the differences in resistant patterns between carbapenems and isolates.

resultsThe overall prevalence of carbapenem resistance by disk diffusion susceptibility testing (DST) for both humans and livestock isolates were 41.7% (80/192). DST-based resistance was identical in both human and livestock isolates (41.7%). The prevalence of carbapenem resistance based on Modified Hodge Test (MHT) was 5% (2/40) and 10% (4/40) for humans and livestock isolates respectively. Both human and livestock isolates, 48.7% (95/192) had the KPC gene, higher than phenotypic expression; 41.7% (80/192). blaKPC gene prevalence was overall similar in human isolates (51%; 49/96) vs livestock isolates (47.9%; 46/96). Approximately, 19% (15/80) of the isolates were phenotypically resistant to carbapenems and over 70% (79/112) of the phenotypically sensitive strains harbored the blaKPC gene.

conclusionOur results suggest that both human and livestock isolates of E. coli in our setting carry the blaKPC gene with a high percentage of strains not actively expressing the blaKPC gene. The finding of fewer isolates carrying the KPC gene than those phenotypically resistant to carbapenems suggests that other mechanisms are playing a role in this phenomenon, calling for further researcher into this phenomenon.

Indexed as

Escherichia coliKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsCross-Sectional StudiesHumansLivestockMicrobial Sensitivity TestsUgandaAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenems

Identifiers

PMID37440483
PMCPMC10343067
OpenAlexW4384156347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.